• 31832 Citations
  • 96 Scopus h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma

Cope, S., Toor, K., Popoff, E., Fonseca, R., Landgren, O., Mateos, M. V., Weisel, K. & Jansen, J. P., Apr 2020, In : Value in Health. 23, 4, p. 441-450 10 p.

Research output: Contribution to journalArticle

2019

Burden of disease progression in patients with multiple myeloma in the US

Hagiwara, M., Panjabi, S., Delea, T., Yucel, E. & Fonseca, R., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Open Access

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

Sahin, I., Kawano, Y., Sklavenitis-Pistofidis, R., Moschetta, M., Mishima, Y., Manier, S., Sacco, A., Carrasco, R., Fonseca, R., Roccaro, A. M., Witzig, T. & Ghobrial, I. M., Apr 9 2019, In : Blood Advances. 3, 7, p. 995-1002 8 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data

Kim, C., Bhatta, S., Cyprien, L., Fonseca, R. & Hernandez, R. K., Feb 1 2019, In : Journal of Bone Oncology. 14, 100215.

Research output: Contribution to journalArticle

4 Scopus citations

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

2018

Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients

González-Calle, V., Slack, A., Keane, N., Luft, S., Pearce, K. E., Ketterling, R. P., Jain, T., Chirackal, S., Reeder, C., Mikhael, J. R., Noel, P., Mayo, A., Adams, R. H., Ahmann, G., Braggio, E. D., Stewart, A. K., Bergsagel, P. L., van Wier, S. A. & Fonseca, R., Apr 6 2018, (Accepted/In press) In : Annals of Hematology. p. 1-10 10 p.

Research output: Contribution to journalArticle

6 Scopus citations
4 Scopus citations

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

Kumar, S. K., Buadi, F. K., LaPlant, B., Halvorson, A., Leung, N., Kapoor, P., Dingli, D. M., Gertz, M., Go, R. S., Bergsagel, P. L., Lin, Y., Dispenzieri, A., Hwa, Y. L., Fonder, A., Hobbs, M., Fonseca, R., Hayman, S. R., Stewart, A. K., Lust, J. A., Mikhael, J. R. & 5 others, Gonsalves, W., Reeder, C., Skacel, T., Rajkumar, S. V. & Lacy, M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 70.

Research output: Contribution to journalArticle

4 Scopus citations

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Selective inhibition of nuclear export with oral selinexor for treatment of relapsed or refractory multiple myeloma

Vogl, D. T., Dingli, D., Cornell, R. F., Huff, C. A., Jagannath, S., Bhutani, D., Zonder, J., Baz, R., Nooka, A., Richter, J., Cole, C., Vij, R., Jakubowiak, A., Abonour, R., Schiller, G., Parker, T. L., Costa, L. J., Kaminetzky, D., Hoffman, J. E., Yee, A. J. & 12 others, Chari, A., Siegel, D., Fonseca, R., Van Wier, S., Ahmann, G., Lopez, I., Kauffman, M., Shacham, S., Saint-Martin, J. R., Picklesimer, C. D., Choe-Juliak, C. & Keith Stewart, A., Jan 1 2018, In : Journal of Clinical Oncology. 36, 9, p. 859-866 8 p.

Research output: Contribution to journalArticle

46 Scopus citations

Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

Jain, T., Kosiorek, H. E., Kung, S. T., Shah, V. S., Dueck, A., Gonzalez-Calle, V., Luft, S., Reeder, C. B., Adams, R., Noel, P., Larsen, J. T., Mikhael, J. R., Bergsagel, P. L., Stewart, A. K. & Fonseca, R., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

2 Scopus citations
2017

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

5 Scopus citations
50 Scopus citations

Hereditary lysozyme amyloidosis variant p.Leu102Ser associates with unique phenotype

Nasr, S. H., Dasari, S., Mills, J. R., Theis, J. D., Zimmermann, M. T., Fonseca, R., Vrana, J. A., Lester, S. J., McLaughlin, B. M., Gillespie, R., Highsmith, W. E. J., Lee, J. J., Dispenzieri, A. & Kurtin, P. J., Feb 1 2017, In : Journal of the American Society of Nephrology. 28, 2, p. 431-438 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity

Sebastian, S., Zhu, Y. X., Braggio, E. D., Shi, C. X., Panchabhai, S. C., Van Wier, S. A., Ahmann, G. J., Chesi, M., Bergsagel, P. L., Stewart, A. K. & Fonseca, R., Feb 23 2017, In : Blood. 129, 8, p. 991-1007 17 p.

Research output: Contribution to journalArticle

11 Scopus citations

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S. K., Gertz, M., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D. M., Go, R. S., Lin, Y., Gonsalves, W., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Precision Medicine in Myeloma: Challenges in Defining an Actionable Approach

González-Calle, V., Keane, N., Braggio, E. D. & Fonseca, R., 2017, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations

Prevalence of BCL-2/J(H) Translocation in Healthy African Americans

Colon-Otero, G., Van Wier, S. A., Ahmann, G. J., Braggio, E. D., Albertie, M. L., Weis, J. A., Ailawadhi, S., Cerhan, J. R., Vishnu, P., Jorgensen, M. S., Foran, J. M., Thomas, C. S. & Fonseca, R., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 51-55 5 p.

Research output: Contribution to journalArticle

Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma

van Beers, E. H., van Vliet, M. H., Kuiper, R., de Best, L., Anderson, K. C., Chari, A., Jagannath, S., Jakubowiak, A., Kumar, S. K., Levy, J. B., Auclair, D., Lonial, S., Reece, D., Richardson, P., Siegel, D. S., Stewart, A. K., Trudel, S., Vij, R., Zimmerman, T. M. & Fonseca, R., 2017, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

5 Scopus citations

Retos y avances hacia la medicina de precisión en el mieloma múltiple

Translated title of the contribution: Towards precision medicine in myeloma: New evidence and challengesGonzález-Calle, V. & Fonseca, R., Jun 1 2017, In : Medicina (Argentina). 77, 3, p. 222-226 5 p.

Research output: Contribution to journalArticle

Trends in overall survival and costs of multiple myeloma, 2000–2014

Fonseca, R., Abouzaid, S., Bonafede, M., Cai, Q., Parikh, K., Cosler, L. & Richardson, P., Jan 20 2017, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

97 Scopus citations
2016

Bone disease in Myeloma: The claws of CRAB

Fonseca, R. & Jain, T., Mar 15 2016, In : Clinical Cancer Research. 22, 6, p. 1301-1303 3 p.

Research output: Contribution to journalArticle

Carfilzomib and the cardiorenal system in myeloma: An endothelial effect?

Rosenthal, A., Luthi, J., Belohlavek, M., Kortüm, K. M., Mookadam, F., Mayo, A., Fonseca, R., Bergsagel, P. L., Reeder, C. B., Mikhael, J. R. & Stewart, A. K., 2016, In : Blood Cancer Journal. 6, 1, e384.

Research output: Contribution to journalArticle

42 Scopus citations

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

Avet-Loiseau, H., Fonseca, R., Siegel, D., Dimopoulos, M. A., Špička, I., Masszi, T., Hájek, R., Rosiñol, L., Goranova-Marinova, V., Mihaylov, G., Maisnar, V., Mateos, M. V., Wang, M., Niesvizky, R., Oriol, A., Jakubowiak, A., Minarik, J., Palumbo, A., Bensinger, W., Kukreti, V. & 4 others, Ben-Yehuda, D., Stewart, A. K., Obreja, M. & Moreau, P., Sep 1 2016, In : Blood. 128, 9, p. 1174-1180 7 p.

Research output: Contribution to journalArticle

64 Scopus citations

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

Borad, M. J., Egan, J. B., Condjella, R. M., Liang, W. S., Fonseca, R., Ritacca, N. R., McCullough, A. E., Barrett, M., Hunt, K. S., Champion, M. D., Patel, M. D., Young, S. W., Silva, A. C., Ho, T. H., Halfdanarson, T. R., Mc Williams, R. R., Lazaridis, K. N., Ramanathan, R. K., Baker, A., Aldrich, J. & 17 others, Kurdoglu, A., Izatt, T., Christoforides, A., Cherni, I., Nasser, S., Reiman, R., Cuyugan, L., McDonald, J., Adkins, J., Mastrian, S. D., Valdez, R., Jaroszewski, D. E., Von Hoff, D. D., Craig, D. W., Stewart, A. K., Carpten, J. D. & Bryce, A. H., 2016, In : Scientific Reports. 6, 1, 25.

Research output: Contribution to journalArticle

11 Scopus citations

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

Bryce, A. H., Borad, M. J., Egan, J. B., Condjella, R. M., Liang, W. S., Fonseca, R., McCullough, A. E., Hunt, K. S., Ritacca, N. R., Barrett, M., Patel, M. D., Young, S. W., Silva, A. C., Ho, T. H., Halfdanarson, T. R., Stanton, M. L., Cheville, J., Swanson, S., Schneider, D. E., Mc Williams, R. R. & 16 others, Baker, A., Aldrich, J., Kurdoglu, A., Izatt, T., Christoforides, A., Cherni, I., Nasser, S., Reiman, R., Cuyugan, L., McDonald, J., Adkins, J., Mastrian, S. D., Von Hoff, D. D., Craig, D. W., Stewart, A. K. & Carpten, J. D., Nov 3 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Erdheim Chester Disease treated successfully with cladribine

Azadeh, N., Tazelaar, H. D., Gotway, M., Mookadam, F. & Fonseca, R., 2016, In : Respiratory Medicine Case Reports. 18, p. 37-40 4 p.

Research output: Contribution to journalArticle

6 Scopus citations

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome

Barrio, S., Shanafelt, T. D., Ojha, J., Chaffee, K. G., Secreto, C., Kortüm, K. M., Pathangey, S., Van-Dyke, D. L., Slager, S. L., Fonseca, R., Kay, N. E. & Braggio, E. D., Jul 29 2016, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

20 Scopus citations

IAP antagonists induce anti-tumor immunity in multiple myeloma

Chesi, M., Mirza, N. N., Garbitt, V. M., Sharik, M. E., Dueck, A., Asmann, Y., Akhmetzyanova, I., Kosiorek, H. E., Calcinotto, A., Riggs, D. L., Keane, N., Ahmann, G. J., Morrison, K. M., Fonseca, R., Lacy, M., Dingli, D. M., Kumar, S. K., Ailawadhi, S., Dispenzieri, A., Buadi, F. & 7 others, Gertz, M., Reeder, C. B., Lin, Y., Chanan Khan, A. A., Stewart, A. K., Fooksman, D. & Bergsagel, P. L., Dec 1 2016, In : Nature Medicine. 22, 12, p. 1411-1420 10 p.

Research output: Contribution to journalArticle

58 Scopus citations

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: Long-term follow-up

Biran, N., Jacobus, S., Vesole, D. H., Callander, N. S., Fonseca, R., Williams, M. E., Abonour, R., Katz, M. S., Rajkumar, S. V., Greipp, P. R. & Siegel, D. S., Sep 2 2016, In : Blood Cancer Journal. 6, 9, e466.

Research output: Contribution to journalArticle

7 Scopus citations

Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients

Kortuem, K. M., Braggio, E. D., Bruins, L., Barrio, S., Shi, C. S., Zhu, Y. X., Tibes, R., Viswanatha, D., Votruba, P., Ahmann, G., Fonseca, R., Jedlowski, P., Schlam, I., Kumar, S. K., Bergsagel, P. L. & Stewart, A. K., 2016, In : Blood Cancer Journal. 6, 2, e397.

Research output: Contribution to journalArticle

30 Scopus citations

PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation

Teoh, P. J., Bi, C., Sintosebastian, C., Tay, L. S., Fonseca, R. & Chng, W. J., 2016, In : Oncotarget. 7, 38, p. 61806-61819 14 p.

Research output: Contribution to journalArticle

14 Scopus citations
2015

Carfilzomib: A cause of drug associated thrombotic microangiopathy

Qaqish, I., Schlam, I. M., Chakkera, H. M., Fonseca, R. & Adamski, J., Aug 24 2015, (Accepted/In press) In : Transfusion and Apheresis Science.

Research output: Contribution to journalArticle

14 Scopus citations

Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia

Ojha, J., Ayres, J., Secreto, C., Tschumper, R., Rabe, K., Van Dyke, D., Slager, S. L., Shanafelt, T., Fonseca, R., Kay, N. E. & Braggio, E. D., Jan 15 2015, In : Blood. 125, 3, p. 492-498 7 p.

Research output: Contribution to journalArticle

36 Scopus citations

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Mayo Phase Consortium, Jan 15 2015, In : Blood. 125, 3, p. 443-448 6 p.

Research output: Contribution to journalArticle

96 Scopus citations

Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature

Coakley, M., Yeneneh, B., Rosenthal, A., Fonseca, R. & Mookadam, F., Nov 29 2015, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

3 Scopus citations

Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas

Braggio, E. D., Van Wier, S., Ojha, J., McPhail, E., Asmann, Y., Egan, J., Da Silva, J. A., Schiff, D., Lopes, M. B., Decker, P. A., Valdez, R., Tibes, R., Eckloff, B., Witzig, T. E., Stewart, A. K., Fonseca, R. & O'Neill, B. P., Sep 1 2015, In : Clinical Cancer Research. 21, 17, p. 3986-3994 9 p.

Research output: Contribution to journalArticle

79 Scopus citations

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

Bi, C., Chung, T. H., Huang, G., Zhou, J., Yan, J., Ahmann, G. J., Fonseca, R. & Chng, W. J., Jan 1 2015, In : Oncotarget. 6, 28, p. 26508-26518 11 p.

Research output: Contribution to journalArticle

33 Scopus citations

Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia

Ojha, J., Secreto, C. R., Rabe, K. G., Van Dyke, D. L., Kortum, K. M., Slager, S. L., Shanafelt, T. D., Fonseca, R., Kay, N. E. & Braggio, E. D., May 1 2015, In : British Journal of Haematology. 169, 3, p. 445-448 4 p.

Research output: Contribution to journalArticle

20 Scopus citations

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M<sup>3</sup>P)

Kortüm, K. M., Langer, C., Monge, J., Bruins, L., Zhu, Y. X., Shi, C. X., Jedlowski, P., Egan, J. B., Ojha, J., Bullinger, L., Kull, M., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H., Stewart, A. K. & Braggio, E. D., Jul 18 2015, In : Annals of Hematology. 94, 7, p. 1205-1211 7 p.

Research output: Contribution to journalArticle

27 Scopus citations

Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma

Stewart, A. K., Jacobus, S., Fonseca, R., Weiss, M., Callander, N. S., Chanan Khan, A. A. & Rajkumar, S. V., Sep 10 2015, In : Blood. 126, 11, p. 1294-1301 8 p.

Research output: Contribution to journalArticle

47 Scopus citations

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., Laplant, B., Roy, V., Reeder, C. B., Lacy, M., Gertz, M., Laumann, K., Thompson, M. A., Witzig, T. E., Buadi, F. K., Rivera, C. E., Mikhael, J. R., Bergsagel, P. L., Kapoor, P., Hwa, L., Fonseca, R., Stewart, A. K., Chanan Khan, A. A., Rajkumar, S. V. & Dispenzieri, A., Aug 14 2015, In : Blood Cancer Journal. 4, e338.

Research output: Contribution to journalArticle

49 Scopus citations

Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in -17p high risk disease

Kortüm, K. M., Langer, C., Monge, J., Bruins, L., Egan, J. B., Zhu, Y. X., Shi, C. X., Jedlowski, P., Schmidt, J., Ojha, J., Bullinger, L., Liebisch, P., Kull, M., Champion, M. D., Van Wier, S., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H. & 2 others, Stewart, A. K. & Braggio, E., Feb 1 2015, In : British journal of haematology. 168, 4, p. 507-510 4 p.

Research output: Contribution to journalArticle

33 Scopus citations

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

66 Scopus citations
2014

Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin

Cesarman-Maus, G., Braggio, E., Lome-Maldonado, C., Morales-Leyte, A. L. & Fonseca, R., Apr 2014, In : Thrombosis research. 133, 4, p. 606-609 4 p.

Research output: Contribution to journalArticle

10 Scopus citations

Activation of TAK1 by MYD88 L265P drives malignant B-cell growth in non-Hodgkin lymphoma

Ansell, S. M., Hodge, L. S., Secreto, F. J., Manske, M., Braggio, E., Price-Troska, T., Ziesmer, S., Li, Y., Johnson, S. H., Hart, S. N., Kocher, J. P. A., Vasmatzis, G., Chanan-Kahn, A., Gertz, M., Fonseca, R., Dogan, A., Cerhan, J. R. & Novak, A. J., Feb 2014, In : Blood cancer journal. 4, 2, 20144.

Research output: Contribution to journalArticle

50 Scopus citations

Activity of 129 single-agent drugs in 228 phase i and II clinical trials in multiple myeloma

Kortuem, K. M., Zidich, K., Schuster, S. R., Khan, M. L., Jimenez-Zepeda, V. H., Mikhael, J. R., Fonseca, R. & Stewart, A. K., Aug 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 4, p. 284-290.e5

Research output: Contribution to journalArticle

12 Scopus citations

Amitriptyline-induced agranulocytosis with bone marrow confirmation

Azadeh, N., Kelemen, K. & Fonseca, R., Oct 1 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 5, p. e183-e185

Research output: Contribution to journalArticle

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Zhu, Y. X., Braggio, E., Shi, C. X., Kortuem, K. M., Bruins, L. A., Schmidt, J. E., Chang, X. B., Langlais, P., Luo, M., Jedlowski, P., LaPlant, B., Laumann, K., Fonseca, R., Bergsagel, P. L., Mikhael, J., Lacy, M., Champion, M. D. & Stewart, A. K., Jul 24 2014, In : Blood. 124, 4, p. 536-545 10 p.

Research output: Contribution to journalArticle

97 Scopus citations